Background Image
Table of Contents Table of Contents
Previous Page  62 / 74 Next Page
Information
Show Menu
Previous Page 62 / 74 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 2, March/April 2019

128

AFRICA

Forum

2016;

26

(3): 35–40.

63. Alpert BS, Quinn DE, Friedman BA. A review of the latest guidelines

for NIBP device validation.

Blood Press Monit

2013;

18

(6): 297–302.

64. Venet R, Miric D, Pavie A, Lacheheb D. Korotkoff sound: the cavitation

hypothesis.

Med Hypoth

2000;

55

(2): 141–146.

65. Cartwright FF. A short hstory of blood pressure measurement.

Proc R

Soc Med

1977;

70

(11): 793–799.

66. European Commission Scientific Committee on Emerging and Newly

Identified Health Risks (SCENIHR). Mercury sphygmomanom-

eters in healthcare and the feasibility of alternatives 2009; Available

from:

http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/

scenihr_o_025.pdf (assessed 5 May 2018).

67. Turner MJ, Speechly C, Bignell N. Sphygmomanometer calibration –

why, how and how often?

Aust Fam Physician

2007;

36

(10): 834–838.

68. National Institute for Health and Care Excellence. Hypertension in

adults: diagnosis and management (CG127), 2011.

69. American College of Cardiology/American Heart Association Task

Force on Clinical Practice Guidelines, 2017 ACC/AHA/AAPA/ABC/

ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the

Prevention, Detection, Evaluation, and Management of High Blood

Pressure in Adults: A Report of the American College of Cardiology/

American Heart Association Task Force on Clinical Practice Guidelines.

Available from:

http://www.onlinejacc.org/content/71/19/e127

(accessed

26 July 2018).

70. Society of Obstetricians and Gynaecologists of Canada (SOGC).

Clinical practice guidelines. Diagnosis, evaluation, and management of

the hypertensive disorders of pregnancy: executive summary. No. 307.

J

Obstet Gynaecol Can

2014;

36

(5): 416–438.

71. Cloutier L, Daskalopoulou S, Padwal R, Lamarre-Cliche M, Bolli P,

McLean D,

et al

. A new algorithm for the diagnosis of hypertension in

Canada.

Can J Cardiol

2015;

31

(15): 620–630.

72. National Department of Health, Republic of South Africa. Guidelines

for maternity care in South Africa: A manual for clinics, commu-

nity health centres and district hospitals. 2015; Available from: https://

www.health-e.org.za/wp-content/uploads/2015/11/Maternal-Care-

Guidelines-2015_FINAL-21.7.15.pdf (accessed 14 July 2018).

73. YK Seedat, Rayner B, Veriava Y, Hypertension guideline working group.

South African Hypertension Guideline 2014.

Cardiovasc J Afr

2014;

25

(6): 288–294.

74. Hartle A, McCormack T, Carlisle J, Anderson S, Pichel A, Beckett N,

et

al

. The measurement of adult blood pressure and management of hyper-

tension before elective surgery: Joint guidelines from the Association of

Anaesthetists of Great Britain and Ireland and the British Hypertension

Society.

Anaesthesia

2016;

71

(3): 326–327.

75. Nathan HL, Duhig K, Hezelgrave NL, Chappell LC, Shennan AH.

Blood pressure measurement in pregnancy.

Obstet Gynaecol

2015;

17

:

91–98.

76. Brown MA, Reiter L, Smith B, Buddle ML, Morris R, Whitworth JA.

Measuring blood pressure in pregnant women: a comparison of direct

and indirect methods.

Am J Obstet Gynecol

1994;

171

(3): 661–667.

77. American College of Obstetricans and Gynecologists (ACOG)

Committee on Obstetric Practice. Committee Opinion No. 692:

Emergent Therapy for Acute-Onset, Severe Hypertension During

Pregnancy and the Postpartum Period.

Obstet Gynaecol

2017;

129

(4):

e90–e95.

78. Berger A. Oscillatory Blood pressure monitoring devices.

Br Med J

2001;

323

(7318): 919.

79. Reay CA, Menses JA, Bousfield DR, Colechin ES, Sims AJ. Buyers’

guide. Hospital grade non-invasive blood pressure monitors, 2008.

Available from:

www.healthcheck.nhs.uk/document.php?o=10

(assessed

19 July 2017).

80. De Greeff A, Beg Z, Gangji Z, Dorney E, Shennan AH. Accuracy of

inflationary versus deflationary oscillometry in pregnancy and preec-

lampsia: OMRON-MIT versus OMRON-M7.

Blood Press Monit

2009;

14

(1): 37–40.

81. Shennan AH, de Greeff A. Pre-eclampsia: etiology and clinical practice.

In: Lyall F, Belfort M, eds.

Measuring Blood Pressure in Pregnancy and

Pre-eclampsia

. United Kingdom: Cambridge University Press, 2007.

82. Chung Y, Brochut M, de Greeff A, Shennan A. Clinical accuracy of

inflationary oscillometry in pregnancy and pre-eclampsia: Omron-MIT

Elite.

Pregnancy Hypertens

2012;

2

: 411–415.

83. Nathan HL, de Greeff A, Hezelgrave NL, Chappell LC, Shennan AH.

Accuracy validation of the Microlife 3AS1-2 blood pressure device in a

pregnant population with low blood pressure.

Blood Press Monit

2015;

20

(5): 299–302.

84. Nathan HL, de Greeff A, Hezelgrave NL, Chappell LC, Shennan AH.

An accurate semiautomated oscillometric blood pressure device for use

in pregnancy (including pre-eclampsia) in a low-income and middle-

income country population: the Microlife 3AS1-2.

Blood Press Monit

2015;

20

(1): 52–55.

85. Chung Y, de Greeff A, Shennan A. Validation and compliance of

a home monitoring device in pregnancy: microlife WatchBP home.

Hypertens Pregnancy

2009;

28

(3): 348–359.

86. Topouchian J, Zelveian P, Asmar R. Validation of the automatic blood

pressure measurements device, the OMRON EVOLV (HEM- 7600

T-E)

®

in pregnancy according to the modified European Society of

Hypertension international protocol (ESH-IP). Available from: http://

www.dableducational.org/Publications/2017/ESH-IP%202010%20

Validation%20of%20OMRON%20EVOLV%20(HEM-7600%20

T-E)%20v2.pdf (accessed 28 August 2018).

87. De Greeff A, Ghosh D, Anthony J, Shennan A. Accuracy assessment

of the Dinamap ProCare 400 in pregnancy and preeclampsia.

Hypertens

Pregnancy

2010;

29

(2): 198–205.

88. De Greeff A, Shennan AH. Clinical accuracy of a low-cost port-

able blood pressure device in pregnancy and pre-eclampsia: the Nissei

DS-400.

Trop Doct

2015;

45

(3): 168–173.

89. Bartosh LF, Dorogova JV, Kuznecova TN, Krylova AV. The testing of

BPLab ambulatory blood pressure monitor on the pregnant in conform-

ity with international protocol of the European Society of Hypertension

(ESH-2001).

Arterial Hypertens

2006;

12

: 3–6.

90. Dorogova IV, Panina ES. Comparison of the BPLab

®

sphygmomanom-

eter for ambulatory blood pressure monitoring with mercury sphyg-

momanometry in pregnant women: validation study according to the

British Hypertension Society protocol.

Vasc Health Risk Manage

2015;

11

: 245–249.

91. Penny JA, Shennan AH, Rushbrook J, Halligan AW, Taylor DJ, De

Sweit M. Validation of the Welch Allyn QuietTrak ambulatory blood

pressure monitor in pregnancy.

Hypertens Pregnancy

1996;

15

(3):

313–321.

92. Vischer AS, Burkard T. Principles of blood pressure measurement –

Current techniques, office vs ambulatory blood pressure measurement.

In: Islam S, ed.

Hypertension: From Basic Research to Clinical Practice.

Switzerland: Springer International Publishing AG; 2017: 85–96.

93. Chung E, Chen G, Alexander B, Cannesson M. Non-invasive continu-

ous blood pressure monitoring: a review of current applications.

Front

Med

2013;

7

(1): 91–101.

94. AnaesthesiaUK. Finapres. Available from:

http://www.frca.co.uk/article.

aspx?articleid=100318 (assessed 21 July 2017).

95. Gupta D, Soskin V, Marjanovic M, Amhaz H, Mazumdar A. Continous

non-invasive arterial pressure device as an adjunct to recognize fluctuat-